Urothelial tract: Renal pelvis, ureter, urinary bladder, and urethra

Sternberg's Diagnostic Surgical Pathology: Sixth Edition

Volumn 2-2, Issue , 2015, Pages

  Reuter, Victor E ^a   Al Ahmadie, Hikmat ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84975144656     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (439)

1. Moore KL. The Developing Human: Clinically Oriented Embryology. Philadelphia: Saunders, 1982.
2. Reuter VE. Histology for Pathologists. New York: Raven Press, 1998.
3. Fawcett DW, Bloom W. A Textbook of Histology. Philadelphia: Saunders, 1986.
4. Ro JY, Ayala AG, el-Naggar A. Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 1987;11:668-673.
5. Vakar-Lopez F, Shen SS, Zhang S, et al. Muscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens. Ann Diagn Pathol 2007;11:395-401.
6. Paner GP, Ro JY, Wojcik EM, et al. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2007;31:1420-1429.
7. Paner GP, Shen SS, Lapetino S, et al. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2009;33:91-98.
8. Miyamoto H, Sharma RB, Illei PB, et al. Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma. Am J Surg Pathol 2010;34:418-422.
9. Philip AT, Amin MB, Tamboli P, et al. Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol 2000;24:1286-1290.
10. Moore KL, Dalley AF, Agur AMR. Clinically Oriented Anatomy. Baltimore, MD: Lippincott Williams & Wilkins, 2006.
11. Morse HD. The etiology and pathology of pyelitis cystica, ureteritis cystica and cystitis cystica. Am J Pathol 1928;4:33-50.
12. Mostofi FK. Potentialities of bladder epithelium. J Urol 1954;71:705-714.
13. Goldstein AM, Fauer RB, Chinn M, et al. New concepts on formation of Brunn's nests and cysts in urinary tract mucosa. Urology 1978;11:513-517.
14. Wiener DP, Koss LG, Sablay B, et al. The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. J Urol 1979;122:317-321.
15. Davies G, Castro JE. Cystitis glandularis. Urology 1977;10:128-129.
16. Young RH, Bostwick DG. Florid cystitis glandularis of intestinal type with mucin extravasation: a mimic of adenocarcinoma. Am J Surg Pathol 1996;20:1462-1468.
17. Edwards PD, Hurm RA, Jaeschke WH. Conversion of cystitis glandularis to adenocarcinoma. J Urol 1972;108:568-570.
18. Lin JI, Yong HS, Tseng CH, et al. Diffuse cystitis glandularis. Associated with adenocarcinomatous change. Urology 1980;15:411-415.
19. Peterson RO. Urologic Pathology. Philadelphia: Lippincott, 1992.
20. Lage JM, Bauer WC, Kelley DR, et al. Histological parameters and pitfalls in the interpretation of bladder biopsies in bacillus Calmette-Guerin treatment of superficial bladder cancer. J Urol 1986;135:916-919.
21. Murphy WM, Soloway MS, Finebaum PJ. Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 1981;126:461-464.
22. Godwin JT, Hanash K. Pathology of bilharzial bladder cancer. Prog Clin Biol Res 1984;162A:95-143.
23. Khafagy MM, el-Bolkainy MN, Mansour MA. Carcinoma of the bilharzial urinary bladder. A study of the associated mucosal lesions in 86 cases. Cancer 1972;30:150-159.
24. Zahran MM, Kamel M, Mooro H, et al. Bilharziasis of urinary bladder and ureter: comparative histopathologic study. Urology 1976;8:73-79.
25. Milles G. Catheter-induced hemorrhagic pseudopolyps of the urinary bladder. JAMA 1965;193:968-969.
26. Eklund P, Johansson S. Polypoid cystitis: a catheter associated lesion of the human bladder. Acta Pathol Microbiol Immunol Scand [A] 1979;87:179-184.
27. Buck EG. Polypoid cystitis mimicking transitional cell carcinoma. J Urol 1984;131:963.
28. Palubinskas AJ. Eosinophilic cystitis. Case report of eosinophilic infiltration of the urinary bladder. Radiology 1960;75:589-591.
29. Frensilli FJ, Sacher EC, Keegan GT. Eosinophilic cystitis: observations on etiology. J Urol 1972;107:595-596.
30. Rubin L, Pincus MB. Eosinophilic cystitis: the relationship of allergy in the urinary tract to eosinophilic cystitis and the pathophysiology of eosinophilia. J Urol 1974;112:457-460.
31. Brown EW. Eosinophilic granuloma of the bladder. J Urol 1960;83:665-668.
32. Hellstrom HR, Davis BK, Shonnard JW. Eosinophilic cystitis. A study of 16 cases. Am J Clin Pathol 1979;72:777-784.
33. Hunner GL. A rare type of bladder ulcer in women: a report of cases. Boston Med Surg J 1915;172:660-662.
34. Parivar F, Bradbrook RA. Interstitial cystitis. Br J Urol 1986;58:239-244.
35. Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978;12:381-392.
36. Larsen S, Thompson SA, Hald T, et al. Mast cells in interstitial cystitis. Br J Urol 1982;54:283-286.
37. Collan Y, Alfthan O, Kivilaakso E, et al. Electron microscopic and histological findings on urinary bladder epithelium in interstitial cystitis. Eur Urol 1976;2:242-247.
38. Sarma KP. On the nature of cystitis follicularis. J Urol 1970;104:709-714.
39. Wallin JE, Thompson SE, Zaidi A, et al. Urethritis in women attending an STD clinic. Br J Vener Dis 1981;57:50-54.
40. Elbadawi A, Malhoski WE, Frank IN. Mucinous urethral caruncle. Urology 1978;12:587-590.
41. Saraf PG, Valvo JR, Frank IN. Congenital posterior urethral valves in an adult. Urology 1984;23:55-57.
42. Nixon WCW. Endometriosis of the bladder. Lancet 1940;1:405-406.
43. Fein RL, Horton BF. Vesical endometriosis: a case report and review of the literature. J Urol 1966;95:45-50.
44. Rubin R. Radiation Biology and Radiation Pathology Syllabus. Chicago, IL: American College of Radiology, 1975:210.
45. Fajardo LF, Berthrong M. Radiation injury in surgical pathology. Part I. Am J Surg Pathol 1978;2:159-199.
46. Jayalakshmamma B, Pinkel D. Urinary-bladder toxicity following pelvic irradiation and simultaneous cyclophosphamide therapy. Cancer 1976;38:701-707.
47. Koss LG. Tumors of the Urinary Bladder. Fascicle 11. Washington, DC: Armed Forces Institute of Pathology, 1975.
48. Warren S. Effects of radiation on normal tissue. Vol. 11. Effects of radiation on the urinary system. Arch Pathol 1942;34:1079-1084.
49. Chan TY, Epstein JI. Radiation or chemotherapy cystitis with "pseudocarcinomatous" features. Am J Surg Pathol 2004;28:909-913.
50. Baker PM, Young RH. Radiation-induced pseudocarcinomatous proliferations of the urinary bladder: a report of 4 cases. Hum Pathol 2000;31:678-683.
51. Lane Z, Epstein JI. Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy. Am J Surg Pathol 2008;32:92-97.
52. el-Mekresh MM, el-Baz MA, Abol-Enein H, et al. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol 1998;82:206-212.
53. Philips FS, Sternberg SS, Cronin AP, et al. Cyclophosphamide and urinary bladder toxicity. Cancer Res 1961;21:1577-1589.
54. Lawrence HJ, Simone J, Aur RJ. Cyclophosphamide-induced hemorrhagic cystitis in children with leukemia. Cancer 1975;36:1572-1576.
55. Beyer-Boon ME, de Voogt HJ, Schaberg A. The effects of cyclophosphamide treatment on the epithelium and stroma of the urinary bladder. Eur J Cancer 1978;14:1029-1035.
56. Pode D, Perlberg S, Steiner D. Busulfan-induced hemorrhagic cystitis. J Urol 1983;130:347-348.
57. Murphy WM, Soloway MS, Lin CJ. Morphologic effects of thio-tepa on mammalian urothelium. Changes in abnormal cells. Acta Cytol 1978;22:550-554.
58. Lichtenfeld FR, McCauley RT, Staples PP. Endometriosis involving the urinary tract: a collective review. Obstet Gynecol Surv 1961;17:762-768.
59. Stewart WW, Ireland GW. Vesical endometriosis in a postmenopausal woman: a case report. J Urol 1977;118:480-481.
60. Pinkert TC, Catlow CE, Straus R. Endometriosis of the urinary bladder in a man with prostatic carcinoma. Cancer 1979;43:1562-1567.
61. Schrodt GR, Alcorn MO, Ibanez J. Endometriosis of the male urinary system: a case report. J Urol 1980;124:722-723.
62. Westney OL, Amundsen CL, McGuire EJ. Bladder endometriosis: conservative management. J Urol 2000;163:1814-1817.
63. Comiter CV. Endometriosis of the urinary tract. Urol Clin North Am 2002;29:625-635.
64. Clement PB, Young RH. Endocervicosis of the urinary bladder. A report of six cases of a benign mullerian lesion that may mimic adenocarcinoma. Am J Surg Pathol 1992;16:533-542.
65. Julie C, Boye K, Desgrippes A, et al. Endocervicosis of the urinary bladder. Immunohistochemical comparative study between a new case and normal uterine endocervices. Pathol Res Pract 2002;198:115-120.
66. Young RH, Clement PB. Mullerianosis of the urinary bladder. Mod Pathol 1996;9:731-737.
67. Kim HJ, Lee TJ, Kim MK, et al. Muellerianosis of the urinary bladder, endocervicosis type: a case report. J Korean Med Sci 2001;16:123-126.
68. Donne C, Vidal M, Buttin X, et al. Mullerianosis of the urinary bladder: clinical and immunohistochemical findings. Histopathology 1998;33:290-292.
69. Melicow MM. Malacoplakia: report of case, review of literature. J Urol 1957;78:33-40.
70. Smith BH. Malacoplakia of the urinary tract: a study of twenty-four cases. Am J Clin Pathol 1965;43:409-417.
71. Melamed MR. The urinary sediment cytology in a case of malakoplakia. Acta Cytol 1962;6:471-474.
72. Lou TY, Teplitz C. Malakoplakia: pathogenesis and ultrastructural morphogenesis. A problem of altered macrophage (phagolysosomal) response. Hum Pathol 1974;5:191-207.
73. Damjanov I, Katz SM. Malakoplakia. Pathol Annu 1981;16:103-126.
74. Stanton MJ, Maxted W. Malacoplakia: a study of the literature and current concepts of pathogenesis, diagnosis and treatment. J Urol 1981;125:139-146.
75. Lewin KJ, Fair WR, Steigbigel RT, et al. Clinical and laboratory studies into the pathogenesis of malacoplakia. J Clin Pathol 1976;29:354-363.
76. Nieh PT, Althausen AF. Malacoplakia of the ureter. J Urol 1979;122:701-702.
77. Sharma TC, Kagan HN, Sheils JP. Malacoplakia of the male urethra. J Urol 1981;125:885-886.
78. Malek RS, Greene LF, Farrow GM. Amyloidosis of the urinary bladder. Br J Urol 1971;43:189-200.
79. Farah RN, Benson DO, Fine G, et al. Primary localized amyloidosis of bladder. Urology 1979;13:200-202.
80. Fujihara S, Glenner GG. Primary localized amyloidosis of the genitourinary tract: immunohistochemical study on eleven cases. Lab Invest 1981;44:55-60.
81. Akhtar M, Valencia M, Thomas AM. Solitary primary amyloidosis of urinary bladder. Light and electron microscopic study. Urology 1978;12:721-724.
82. Primrose JN, McKean M, Desai S. Primary amyloidosis of ureter. Urology 1985;25:650-652.
83. Dias R, Fernandes M, Patel RC, et al. Amyloidosis of renal pelvis and urinary bladder. Urology 1979;14:401-404.
84. Vasudevan P, Stein AM, Pinn VW, et al. Primary amyloidosis of urethra. Urology 1981;17:181-183.
85. Dounis A, Bourounis M, Mitropoulos D. Primary localized amyloidosis of the urethra. Eur Urol 1985;11:344-345.
86. Miller A. The aetiology and treatment of diverticulum of the bladder. Br J Urol 1958;30:43-56.
87. Kertsschmer HL. Diverticula of the urinary bladder: a clinical study of 236 cases. Surg Gynecol Obstet 1940;71:491-503.
88. Fox M, Power RF, Bruce AW. Diverticulum of the bladder: presentation and evaluation of treatment of 115 cases. Br J Urol 1962;34:286-298.
89. Schiff M, Jr., Lytton B. Congenital diverticulum of the bladder. J Urol 1970;104:111-115.
90. Barrett DM, Malek RS, Kelalis PP. Observations on vesical diverticulum in childhood. J Urol 1976;116:234-236.
91. Abeshouse BS. Primary carcinoma in a diverticulum of the bladder: a report of four cases and a review of the literature. J Urol 1943;49:534-547.
92. Faysal MH, Freiha FS. Primary neoplasm in vesical diverticula. A report of 12 cases. Br J Urol 1981;53:141-143.
93. Ward MP. Sarcoma of vesical diverticula. Br J Urol 1958;30:57-59.
94. Cochran ST, Waisman J, Barbaric ZL. Radiographic and microscopic findings in multiple ureteral diverticula. Radiology 1980;137:631-636.
95. Coddington CC, Knab DR. Urethral diverticulum: a review. Obstet Gynecol Surv 1983;38:357-364.
96. Oesch I, Kummer M, Bettex M. Congenital urethral diverticula in boys. Eur Urol 1983;9:139-141.
97. Tesluk H. Primary adenocarcinoma of female urethra associated with diverticula. Urology 1981;17:197-199.
98. Cea PC, Ward JN, Lavengood RW, Jr., et al. Mesonephric adenocarcinomas in urethral diverticula. Urology 1977;10:58-61.
99. Wynder EL, Goldsmith R. The epidemiology of bladder cancer: a second look. Cancer 1977;40:1246-1268.
100. Clayson DB. Occupational bladder cancer. Prev Med 1976;5:228-244.
101. Ward E, Carpenter A, Markowitz S, et al. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst 1991;83:501-506.
102. Anthony HM, Thomas GM, Cole P, et al. Tumors of the urinary bladder: an analysis of the occupations of 1,030 patients in Leeds, England. J Natl Cancer Inst 1971;46:1111-1113.
103. Cole P, Hoover R, Friedell GH. Occupation and cancer of the lower urinary tract. Cancer 1972;29:1250-1260.
104. Schottenfeld D. Cancer Epidemiology and Prevention. Springfield, IL: Charles C. Thomas, 1975.
105. Wynder EL, Onderdonk J, Mantel N. An epidemiological investigation of cancer of the bladder. Cancer 1963;16:1388-1407.
106. Cole P. Coffee-drinking and cancer of the lower urinary tract. Lancet 1971;1:1335-1337.
107. Cohen SM, Arai M, Jacobs JB, et al. Promoting effect of saccharin and dl-tryptophan in urinary bladder carcinogenesis. Cancer Res 1979;39:1207-1217.
108. Kessler, II. Non-nutritive sweeteners and human bladder cancer: preliminary findings. J Urol 1976;115:143-146.
109. Morrison AS, Buring JE. Artificial sweeteners and cancer of the lower urinary tract. N Engl J Med 1980;302:537-541.
110. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975;15:617-631.
111. Gaakeer HA, De Ruiter HJ. Carcinoma of the renal pelvis following the abuse of phenacetin-containing analgesic drugs. Br J Urol 1979;51:188-192.
112. Lomax-Smith JD, Seymour AE. Neoplasia in analgesic nephropathy. A urothelial field change. Am J Surg Pathol 1980;4:565-572.
113. Fairchild WV, Spence CR, Solomon HD, et al. The incidence of bladder cancer after cyclophosphamide therapy. J Urol 1979;122:163-164.
114. Seo IS, Clark SA, McGovern FD, et al. Leiomyosarcoma of the urinary bladder. 13 years after cyclophosphamide therapy for Hodgkin's disease. Cancer 1985;55:1597-1603.
115. Eble J, Sauter G, Epstein J, et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.
116. Jewett HJ, Strong GH. Carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J Urol 1946;55:366-372.
117. Jewett HJ. Carcinoma of the bladder: influence of depth infiltration on the 5-year results following complete extirpation of the primary growth. J Urol 1952;67:672-676.
118. Marshall VF. The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. J Urol 1952;68:714-723.
119. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag, 2010.
120. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. Journal of Urology 2001;165:1111-1116.
121. Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006;24:3967-3972.
122. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 2006;176:2414-2422.
123. Smith JA, Jr., Batata M, Grabstald H, et al. Preoperative irradiation and cystectomy for bladder cancer. Cancer 1982;49:869-873.
124. Pagano F, Bassi P, Galetti TP, et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45-50.
125. Richie JP, Skinner DG, Kaufman JJ. Radical cystectomy for carcinoma of the bladder: 16 years of experience. J Urol 1975;113:186-189.
126. Abel PD. Prognostic indices in transitional cell carcinoma of the bladder. Br J Urol 1988;62:103-109.
127. Herr HW, Jakse G, Sheinfeld J. The t1 bladder tumor. Semin Urol 1990;8:254-261.
128. Reuter VE. Pathology of bladder cancer: assessment of the primary lesion and response to therapy. Prog Clin Biol Res 1990;353:45-56.
129. Abel PD, Henderson D, Bennett MK, et al. Differing interpretations by pathologists of the pt category and grade of transitional cell cancer of the bladder. Br J Urol 1988;62:339-342.
130. Abel PD, Hall RR, Williams G. Should pt1 transitional cell cancers of the bladder still be classified as superficial? Br J Urol 1988;62:235-239.
131. Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997;21:1057-1068.
132. Younes M, Sussman J, True LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990;66:543-548.
133. Hasui Y, Osada Y, Kitada S, et al. Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 1994;43:782-786.
134. Angulo JC, Lopez JI, Grignon DJ, et al. Muscularis mucosa differentiates two populations with different prognosis in stage t1 bladder cancer. Urology 1995;45:47-53.
135. Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA). Cancer Res 1977;37:2907-2910.
136. Loening S, Narayana A, Yoder L, et al. Factors influencing the recurrence rate of bladder cancer. J Urol 1980;123:29-31.
137. Kern WH. The grade and pathologic stage of bladder cancer. Cancer 1984;53:1185-1189.
138. Heney NM, Proppe K, Prout GR, Jr., et al. Invasive bladder cancer: tumor configuration, lymphatic invasion and survival. J Urol 1983;130:895-897.
139. Fossa SD, Reitan JB, Ous S, et al. Prediction of tumour progression in superficial bladder carcinoma. Eur Urol 1985;11:1-5.
140. Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-1086.
141. Skinner DG. Current state of classification and staging of bladder cancer. Cancer Res 1977;37:2838-2842.
142. Young RH, Oliva E. Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. Am J Surg Pathol 1996;20:1448-1454.
143. Brawn PN. The origin of invasive carcinoma of the bladder. Cancer 1982;50:515-519.
144. Prout GR, Jr., Griffin PP, Shipley WU. Bladder carcinoma as a systemic disease. Cancer 1979;43:2532-2539.
145. Kakizoe T, Tobisu K, Takai K, et al. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Cancer Res 1988;48:2299-2303.
146. Larsen MP, Steinberg GD, Brendler CB, et al. Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 1990;3:83-88.
147. Leissner J, Koeppen C, Wolf HK. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy. J Urol 2003;169:955-960.
148. Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005;23:6533-6539.
149. Genega EM, Hutchinson B, Reuter VE, et al. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol 2000;13:1186-1191.
150. McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin Diagn Pathol 2005;22:69.
151. Raspollini MR, Nesi G, Baroni G, et al. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol 2005;13:358-362.
152. Lopez-Beltran A, Croghan GA, Croghan I, et al. Cell and tumor markers' immunohistochemistry in transitional cell carcinoma of the bladder. Urol Int 1993;50:61-64.
153. Higgins JP, Kaygusuz G, Wang L, et al. Placental s100 (s100p) and gata3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007;31:673-680.
154. Liu H, Shi J, Wilkerson ML, et al. Immunohistochemical evaluation of gata3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 2012;138:57-64.
155. Ordonez NG. Value of gata3 immunostaining in tumor diagnosis: a review. Adv Anat Pathol 2013;20:352-360.
156. Mostofi FK, Sobin LH, Torloni H. Histological Typing of Urinary Bladder Tumors: International Classification of Tumors. Geneva, Switzerland: World Health Organization, 1973.
157. Ash JE. Epithelial tumors of the bladder. J Urol 1940;44:135-145.
158. Friedell GH, Parija GC, Nagy GK, et al. The pathology of human bladder cancer. Cancer 1980;45:1823-1831.
159. Koss LG. Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum Pathol 1979;10:533-548.
160. Soto EA, Friedell GH, Tiltman AJ. Bladder cancer as seen in giant histologic sections. Cancer 1977;39:447-455.
161. Kakizoe T, Matsumoto K, Nishio Y, et al. Analysis of 90 step-sectioned cystectomized specimens of bladder cancer. J Urol 1984;131:467-472.
162. Althausen AF, Prout GR, Jr., Daly JJ. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 1976;116:575-580.
163. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965;130:371-378.
164. Lerman RI, Hutter RV, Whitmore WF, Jr. Papilloma of the urinary bladder. Cancer 1970;25:333-342.
165. Gilbert HA, Logan JL, Kagan AR, et al. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J Urol 1978;119:488-492.
166. Jordan AM, Weingarten J, Murphy WM. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 1987;60:2766-2774.
167. Cytology and histopathology of bladder cancer cases in a prospective longitudinal study. National Bladder Cancer Collaborative Group A. Cancer Res 1977;37:2911-2915.
168. Murphy WM, Beckwith JB, Farrow GM. Tumors of the Kidney, Bladder and Related Urinary Structures. Washington, DC: Armed Forces Institute of Pathology, 1994.
169. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee. Am J Surg Pathol 1998;22:1435-1448.
170. Reuter VE, Epstein JI, Amin MB, et al. The "WHO/ISUP consensus classification of urothelial (transitional cell) neoplasms": continued discussion. Hum Pathol 1999;30:879-880.
171. Helpap B. [New WHO classification of urothelial carcinoma of the urinary bladder]. Verh Dtsch Ges Pathol 2002;86:57-66.
172. Mostofi FK, Davis CJ. Histological Typing of Kidney Tumours. Berlin, NY: Springer, 1998.
173. Malmstrom PU, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cance. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 1987;21:185-195.
174. Herr HW, Donat SM, Reuter VE. Management of low grade papillary bladder tumors. J Urol 2007;178:1201-1205; discussion 1205.
175. Miyamoto H, Brimo F, Schultz L, et al. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-world health organization/international society of urological pathology classification cohort from a single academic center. Arch Pathol Lab Med 2010;134:1160-1163.
176. Chow NH, Cairns P, Eisenberger CF, et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000;89:514-518.
177. Cheng L, Darson M, Cheville JC, et al. Urothelial papilloma of the bladder. Clinical and biologic implications. Cancer 1999;86:2098-2101.
178. McKenney JK, Amin MB, Young RH. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases. Mod Pathol 2003;16:623-629.
179. Magi-Galluzzi C, Epstein JI. Urothelial papilloma of the bladder: a review of 34 de novo cases. Am J Surg Pathol 2004;28:1615-1620.
180. DeMeester LJ, Farrow GM, Utz DC. Inverted papillomas of the urinary bladder. Cancer 1975;36:505-513.
181. Henderson DW, Allen PW, Bourne AJ. Inverted urinary papilloma: report of five cases and review of the literature. Virchows Arch A Pathol Anat Histol 1975;366:177-186.
182. Caro DJ, Tessler A. Inverted papilloma of the bladder: a distinct urological lesion. Cancer 1978;42:708-713.
183. Anderstrom C, Johansson S, Pettersson S. Inverted papilloma of the urinary tract. J Urol 1982;127:1132-1134.
184. Lazarevic B, Garret R. Inverted papilloma and papillary transitional cell carcinoma of urinary bladder: report of four cases of inverted papilloma, one showing papillary malignant transformation and review of the literature. Cancer 1978;42:1904-1911.
185. Whitesel JA. Inverted papilloma of the urinary tract: malignant potential. J Urol 1982;127:539-540.
186. Stein BS, Rosen S, Kendall AR. The association of inverted papilloma and transitional cell carcinoma of the urothelium. J Urol 1984;131:751-752.
187. Assor D. Inverted papilloma of the renal pelvis. J Urol 1976;116:654.
188. Lausten GS, Anagnostaki L, Thomsen OF. Inverted papilloma of the upper urinary tract. Eur Urol 1984;10:67-70.
189. Broussard JN, Tan PH, Epstein JI. Atypia in inverted urothelial papillomas: pathology and prognostic significance. Hum Pathol 2004;35:1499-1504.
190. Jones TD, Zhang S, Lopez-Beltran A, et al. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007;31:1861-1867.
191. Uyama T, Moriwaki S. Inverted papilloma with malignant change of renal pelvis. Urology 1981;17:200-201.
192. Holmang S. Follow-up of patients with noninvasive and superficially invasive bladder cancer. Semin Urol Oncol 2000;18:273-279.
193. Murphy WM. Current topics in the pathology of bladder cancer. Pathol Annu 1983;18(Pt 1):1-25.
194. Murphy WM, Irving CC. The cellular features of developing carcinoma in murine urinary bladder. Cancer 1981;47:514-522.
195. Murphy WM, Soloway MS. Developing carcinoma (dysplasia) of the urinary bladder. Pathol Annu 1982;17(Pt 1):197-217.
196. Nagy GK, Frable WJ, Murphy WM. Classification of premalignant urothelial abnormalities. A Delphi study of the national bladder cancer collaborative group a. Pathol Annu 1982;17(Pt 1):219-233.
197. Amin MB, Grignon DJ, Eble JN, et al. Intraepithelial lesions of the urothelium: an interobserver reproducibility study with proposed terminology and histologic criteria. Mod Pathol 1997;10:69A.
198. Taylor DC, Bhagavan BS, Larsen MP, et al. Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am J Surg Pathol 1996;20:1481-1488.
199. Robertson AJ, Beck JS, Burnett RA, et al. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol 1990;43:17-21.
200. Hofstadter F, Delgado R, Jakse G, et al. Urothelial dysplasia and carcinoma in situ of the bladder. Cancer 1986;57:356-361.
201. Rubben H, Lutzeyer W, Fischer N, et al. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 1988;139:283-285.
202. Smith G, Elton RA, Beynon LL, et al. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Br J Urol 1983;55:665-669.
203. Koss LG, Nakanishi I, Freed SZ. Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. Urology 1977;9:442-455.
204. Murphy WM, Nagy GK, Rao MK, et al. "Normal" urothelium in patients with bladder cancer: a preliminary report from the National Bladder Cancer Collaborative Group A. Cancer 1979;44:1050-1058.
205. Prout GR, Jr., Griffin PP, Daly JJ, et al. Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer 1983;52:524-532.
206. Kakizoe T, Matumoto K, Nishio Y, et al. Significance of carcinoma in situ and dysplasia in association with bladder cancer. J Urol 1985;133:395-398.
207. Utz DC, Farrow GM, Rife CC, et al. Carcinoma in situ of the bladder. Cancer 1980;45:1842-1848.
208. Zincke H, Utz DC. Review of mayo clinic experience with carcinoma in situ. Urology 1986;27:288.
209. Melamed MR, Voutsa NG, Grabstald H. Natural history and clinical behavior of in situ carcinoma of the human urinary bladder. Cancer 1964;17:1533-1545.
210. Farrow GM, Utz DC, Rife CC, et al. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res 1977;37:2794-2798.
211. Melamed MR, Voutsa NG, Grabstald H. Natural history and clinical behavior of in situ carcinoma of the human urinary bladder. 1964. CA Cancer J Clin 1993;43:348-370.
212. Weinstein RS, Miller AW, 3rd, Pauli BU. Carcinoma in situ: comments on the pathobiology of a paradox. Urol Clin North Am 1980;7:523-531.
213. Turner AG. Pagetoid lesions associated with carcinoma of the bladder. J Urol 1980;123:124-126.
214. Tomaszewski JE, Korat OC, LiVolsi VA, et al. Paget's disease of the urethral meatus following transitional cell carcinoma of the bladder. J Urol 1986;135:368-370.
215. Powell FC, Bjornsson J, Doyle JA, et al. Genital Paget's disease and urinary tract malignancy. J Am Acad Dermatol 1985;13:84-90.
216. Chan TY, Epstein JI. In situ adenocarcinoma of the bladder. Am J Surg Pathol 2001;25:892-899.
217. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001; 165:1111-1116.
218. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: a contemporary series. J Urol 2001;165:1111-1116.
219. Tannenbaum M. Inflammatory proliferative lesion of urinary bladder: squamous metaplasia. Urology 1976;7:428-429.
220. Guo CC, Fine SW, Epstein JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am J Surg Pathol 2006;30:883-891.
221. Khan MS, Thornhill JA, Gaffney E, et al. Keratinising squamous metaplasia of the bladder: natural history and rationalization of management based on review of 54 years experience. Eur Urol 2002;42:469-474.
222. Bissada NK, Cole AT, Fried FA. Extensive condylomas acuminata of the entire male urethra and the bladder. J Urol 1974;112:201-203.
223. Debenedictis TJ, Marmar ML, Praiss DE. Intraurethral condylomas acuminata: management and review of the literature. J Urol 1977;118:767-769.
224. Keating MA, Young RH, Carr CP, et al. Condyloma acuminatum of the bladder and ureter: case report and review of the literature. J Urol 1985;133:465-467.
225. Cheng L, Leibovich BC, Cheville JC, et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000;88:1679-1686.
226. Walther M, O'Brien DP, 3rd, Birch HW. Condylomata acuminata and verrucous carcinoma of the bladder: case report and literature review. J Urol 1986;135:362-365.
227. Faysal MH. Squamous cell carcinoma of the bladder. J Urol 1981;126:598-599.
228. Newman DM, Brown JR, Jay AC, et al. Squamous cell carcinoma of the bladder. J Urol 1968;100:470-473.
229. Rogers CG, Palapattu GS, Shariat SF, et al. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder. J Urol 2006;175:2048-2053; discussion 2053.
230. Wall RL, Clausen KP. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 1975;293:271-273.
231. Blochin EB, Park KJ, Tickoo SK, et al. Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection. Mod Pathol 2012;25:1534-1542.
232. el-Sebai I, Sherif M, el-Bolkainy MN, et al. Verrucose squamous carcinoma of bladder. Urology 1974;4:407-410.
233. Wyatt JK, Craig I. Verrucous carcinoma of urinary bladder. Urology 1980;16:97-99.
234. Holck S, Jorgensen L. Verrucous carcinoma of urinary bladder. Urology 1983;22:435-437.
235. Sternberg SS. Histology for Pathologists. Philadelphia: Lippincott-Raven, 1997.
236. Bhagavan BS, Tiamson EM, Wenk RE, et al. Nephrogenic adenoma of the urinary bladder and urethra. Hum Pathol 1981;12:907-916.
237. Stilmant MM, Siroky MB. Nephrogenic adenoma associated with intravesical bacillus Calmette-Guerin treatment: a report of 2 cases. J Urol 1986;135:359-361.
238. Navarre RJ, Jr., Loening SA, Platz C, et al. Nephrogenic adenoma: a report of 9 cases and review of the literature. J Urol 1982;127:775-779.
239. Molland EA, Trott PA, Paris AM, et al. Nephrogenic adenoma: a form of adenomatous metaplasia of the bladder. A clinical and electron microscopical study. Br J Urol 1976;48:453-462.
240. Ford TF, Watson GM, Cameron KM. Adenomatous metaplasia (nephrogenic adenoma) of urothelium. An analysis of 70 cases. Br J Urol 1985;57:427-433.
241. Mazal PR, Schaufler R, Altenhuber-Muller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med 2002;347:653-659.
242. Rahemtullah A, Oliva E. Nephrogenic adenoma: an update on an innocuous but troublesome entity. Adv Anat Pathol 2006;13:247-255.
243. Engel RM, Wilkinson HA. Bladder exstrophy. J Urol 1970;104:699-704.
244. Nielsen K, Nielsen KK. Adenocarcinoma in exstrophy of the bladder-the last case in Scandinavia? A case report and review of literature. J Urol 1983;130:1180-1182.
245. Assor D. A villous tumor of the bladder. J Urol 1978;119:287-288.
246. Miller DC, Gang DL, Gavris V, et al. Villous adenoma of the urinary bladder: a morphologic or biologic entity? Am J Clin Pathol 1983;79:728-731.
247. Newman J, Antonakopoulos GN. Widespread mucous metaplasia of the urinary bladder with nephrogenic adenoma. Arch Pathol Lab Med 1985;109:560-563.
248. Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol 1999;23:764-771.
249. Seibel JL, Prasad S, Weiss RE, et al. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy. Hum Pathol 2002;33:236-241.
250. Wheeler JD, Hill WT. Adenocarcinoma involving the urinary bladder. Cancer 1954;7:119-135.
251. Mostofi FK, Thomson RV, Dean AL. Mucous adenocarcinoma of the urinary bladder. Cancer 1955;8:741-758.
252. Nocks BN, Heney NM, Daly JJ. Primary adenocarcinoma of urinary bladder. Urology 1983;21:26-29.
253. Anderstrom C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer 1983;52:1273-1280.
254. Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer 1991;67:2165-2172.
255. Jones WA, Gibbons RP, Correa RJ, Jr., et al. Primary adenocarcinoma of bladder. Urology 1980;15:119-122.
256. Malek RS, Rosen JS, O'Dea MJ. Adenocarcinoma of bladder. Urology 1983;21:357-359.
257. Shaaban AA, Elbaz MA, Tribukait B. Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases. Urology 1998;51:469-476.
258. Dean AL, Mostofi FK, Thompson RV. A restudy of the first fourteen hundred tumors in the bladder tumor registry. J Urol 1954;74:571-590.
259. Melicow MM. Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J Urol 1955;74:498-521.
260. Bischoff W, Bohm N. Adenocarcinoma of the appendix penetrating the bladder. J Urol 1980;123:123.
261. Braun EV, Ali M, Fayemi AO, et al. Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of a case. Cancer 1981;47:1430-1435.
262. Poore TE, Egbert B, Jahnke R, et al. Signet ring cell adenocarcinoma of the bladder: linitis plastica variant. Arch Pathol Lab Med 1981;105:203-204.
263. Choi H, Lamb S, Pintar K, et al. Primary signet-ring cell carcinoma of the urinary bladder. Cancer 1984;53:1985-1990.
264. Bernstein SA, Reuter VE, Carroll PR, et al. Primary signet-ring cell carcinoma of urinary bladder. Urology 1988;31:432-436.
265. Grignon DJ, Ro JY, Ayala AG, et al. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 1991;95:13-20.
266. Dayyani F, Czerniak BA, Sircar K, et al. Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. J Urol 2013;189:1656-1661.
267. Pontes JE, Oldford JR. Metastatic breast carcinoma to the bladder. J Urol 1970;104:839-842.
268. Al-Ahmadie H, Iyer G, Mehra R, et al. E-cadherin (cdh1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology. Mod Pathol 2013;26:191A.
269. Skor AB, Warren MM. Mesonephric adenocarcinoma of bladder. Urology 1977;10:64-65.
270. Schultz RE, Bloch MJ, Tomaszewski JE, et al. Mesonephric adenocarcinoma of the bladder. J Urol 1984;132:263-265.
271. Young RH, Scully RE. Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol 1985;9:816-826.
272. Oliva E, Amin MB, Jimenez R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol 2002;26:190-197.
273. Schubert GE, Pavkovic MB, Bethke-Bedurftig BA. Tubular urachal remnants in adult bladders. J Urol 1982;127:40-42.
274. Johnson DE, Hodge GB, Abdul-Karim FW, et al. Urachal carcinoma. Urology 1985;26:218-221.
275. Jakse G, Schneider HM, Jacobi GH. Urachal signet-ring cell carcinoma, a rare variant of vesical adenocarcinoma: incidence and pathological criteria. J Urol 1978;120:764-766.
276. Alonso-Gorrea M, Mompo-Sanchis JA, Jorda-Cuevas M, et al. Signet ring cell adenocarcinoma of the urachus. Eur Urol 1985;11:282-284.
277. Ghazizadeh M, Yamamoto S, Kurokawa K. Clinical features of urachal carcinoma in japan: review of 157 patients. Urol Res 1983;11:235-238.
278. Gopalan A, Sharp DS, Fine SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009;33:659-668.
279. Eble JN, Hull MT, Rowland RG, et al. Villous adenoma of the urachus with mucusuria: a light and electron microscopic study. J Urol 1986;135:1240-1244.
280. Hayman J. Carcinoma of the urachus. Pathology 1984;16:167-171.
281. Mills SE, Wolfe JT, 3rd, Weiss MA, et al. Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 1987;11:606-617.
282. Davis BH, Ludwig ME, Cole SR, et al. Small cell neuroendocrine carcinoma of the urinary bladder: report of three cases with ultrastructural analysis. Ultrastruct Pathol 1983;4:197-204.
283. Reyes CV, Soneru I. Small cell carcinoma of the urinary bladder with hypercalcemia. Cancer 1985;56:2530-2533.
284. Grignon DJ, Ro JY, Ayala AG, et al. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 1992;69:527-536.
285. Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol 1984;131:1-8.
286. Herr HW, Bochner BH, Sharp D, et al. Urachal carcinoma: contemporary surgical outcomes. J Urol 2007;178:74-78; discussion 78.
287. Alijo Serrano F, Sanchez-Mora N, Angel Arranz J, et al. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Am J Clin Pathol 2007;128:733-739.
288. Jones TD, Kernek KM, Yang XJ, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 2005;36:718-723.
289. Ucci AA, Alroy J, Tallberg K, et al. Neuroendocrine cells in squamous metaplasia, inverted papillomas, and adenocarcinomas of the urinary bladder. Lab Invest 1985;52:71A.
290. Smith A. Neurosecretory cells in carcinoma in situ of the urinary bladder-an incidental finding. Ultrastruct Pathol 1985;8:267.
291. Lopez-Beltran A, Cheng L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006;37:1371-1388.
292. Lapham RL, Grignon D, Ro JY. Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens. Semin Diagn Pathol 1997;14:109-122.
293. Toma H, Yamashita N, Nakazawa H, et al. Transitional cell carcinoma with osteoid metaplasia. Urology 1986;27:174-176.
294. Eble JN, Young RH. Stromal osseous metaplasia in carcinoma of the bladder. J Urol 1991;145:823-825.
295. Komatsu H, Kinoshita K, Mikata N, et al. Spindle and giant cell carcinoma of the bladder. Report of 3 cases. Eur Urol 1985;11:141-144.
296. Holtz F, Fox JE, Abell MR. Carcinosarcoma of the urinary bladder. Cancer 1972;29:294-304.
297. Jao W, Soto JM, Gould VE. Squamous carcinoma of bladder with pseudosarcomatous stroma. Arch Pathol 1975;99:461-466.
298. Jones EC, Young RH. Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. Mod Pathol 1997;10:908-916.
299. Kanno J, Sakamoto A, Washizuka M, et al. Malignant mixed mesodermal tumor of bladder occurring after radiotherapy for cervical cancer: report of a case. J Urol 1985;133:854-856.
300. Smith JA, Jr., Herr HW, Middleton RG. Bladder carcinosarcoma: histologic variation in metastatic lesions. J Urol 1983;129:829-831.
301. Kusaba Y, Yushita Y, Suzu H, et al. Carcinosarcoma of the bladder. J Urol 1984;131:118-119.
302. Tungekar MF, Al Adnani MS. Sarcomas of the bladder and prostate: the role of immunohistochemistry and ultrastructure in diagnosis. Eur Urol 1986;12:180-183.
303. Drew PA, Furman J, Civantos F, et al. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996;9:989-994.
304. Wasco MJ, Daignault S, Bradley D, et al. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases. Hum Pathol 2010;41:163-171.
305. Young RH, Zukerberg LR. Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol 1991;96:635-639.
306. Cox R, Epstein JI. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Am J Surg Pathol 2011;35:1337-1342.
307. Amin MB, Ro JY, Lee KM, et al. Lymphoepithelioma-like carcinoma of the urinary bladder. Am J Surg Pathol 1994;18:466-473.
308. Holmang S, Borghede G, Johansson SL. Bladder carcinoma with lymphoepithelioma-like differentiation: a report of 9 cases. J Urol 1998;159:779-782.
309. Lopez-Beltran A, Luque RJ, Vicioso L, et al. Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. Virchows Arch 2001;438:552-557.
310. Williamson SR, Zhang S, Lopez-Beltran A, et al. Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol 2011;35:474-483.
311. Tamas EF, Nielsen ME, Schoenberg MP, et al. Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases. Mod Pathol 2007;20:828-834.
312. Amin MB, Ro JY, el-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994;18:1224-1232.
313. Johansson SL, Borghede G, Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol 1999;161:1798-1802.
314. Samaratunga H, Khoo K. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 2004;45:55-64.
315. Alvarado-Cabrero I, Sierra-Santiesteban FI, Mantilla-Morales A, et al. Micropapillary carcinoma of the urothelial tract. A clinicopathologic study of 38 cases. Ann Diagn Pathol 2005;9:1-5.
316. Fairey AS, Daneshmand S, Wang L, et al. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol 2013;32:110-116.
317. Wang JK, Boorjian SA, Cheville JC, et al. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis. World J Urol 2012;30:801-806.
318. Spaliviero M, Dalbagni G, Bochner BH, et al. Clinical outcome of patients with t1 micropapillary urothelial carcinoma of the bladder. J Urol 2014;192:702-707.
319. Ching CB, Amin MB, Tubbs RR, et al. Her2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Mod Pathol 2011;24:1111-1119.
320. Huang H, Jadallah S, Chen YB, et al. Her2 expression in urothelial carcinoma with micropapillary morphology: preferential overexpression by the micropapillary component. Lab Invest 2013;93:219a.
321. Dennis PM, Turner AG. Primary choriocarcinoma of the bladder evolving from a transitional cell carcinoma. J Clin Pathol 1984;37:503-505.
322. Gallagher L, Lind R, Oyasu R. Primary choriocarcinoma of the urinary bladder in association with undifferentiated carcinoma. Hum Pathol 1984;15:793-795.
323. Shah VM, Newman J, Crocker J, et al. Ectopic beta-human chorionic gonadotropin production by bladder urothelial neoplasia. Arch Pathol Lab Med 1986;110:107-111.
324. Yamase HT, Wurzel RS, Nieh PT, et al. Immunohistochemical demonstration of human chorionic gonadotropin in tumors of the urinary bladder. Ann Clin Lab Sci 1985;15:414-417.
325. Kawamura J, Rhinsho K, Taki Y, et al. Choriocarcinoma and undifferentiated cell carcinoma of the bladder with gonadotropin secretion. J Urol 1979;121:684-686.
326. Batata MA, Whitmore WF, Hilaris BS, et al. Primary carcinoma of the ureter: a prognostic study. Cancer 1975;35:1626-1632.
327. Grabstald H, Whitmore WF, Melamed MR. Renal pelvic tumors. JAMA 1971;218:845-854.
328. Nocks BN, Heney NM, Daly JJ, et al. Transitional cell carcinoma of renal pelvis. Urology 1982;19:472-477.
329. McCarron JP, Mills C, Vaughn ED, Jr. Tumors of the renal pelvis and ureter: current concepts and management. Semin Urol 1983;1:75-81.
330. Johansson S, Angervall L, Bengtsson U, et al. A clinicopathologic and prognostic study of epithelial tumors of the renal pelvis. Cancer 1976;37:1376-1383.
331. Tickoo SK, Gopalan A, Tu JJ, et al. Estrogen and progesterone-receptor-positive stroma as a non-tumorous proliferation in kidneys: a possible metaplastic response to obstruction. Mod Pathol 2007;21:60-65.
332. Genega EM, Kapali M, Torres-Quinones M, et al. Impact of the 1998 world health organization/international society of urological pathology classification system for urothelial neoplasms of the kidney. Mod Pathol 2005;18:11-18.
333. Olgac S, Mazumdar M, Dalbagni G, et al. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 2004;28:1545-1552.
334. Linker DG, Whitmore WF. Ureteral carcinoma in situ. J Urol 1975;113:777-780.
335. Craig JR, Hart WR. Benign polyps with prostatic-type epithelium of the urethra. Am J Clin Pathol 1975;63:343-347.
336. Walker AN, Mills SE, Fechner RE, et al. Epithelial polyps of the prostatic urethra. A light-microscopic and immunohistochemical study. Am J Surg Pathol 1983;7:351-356.
337. Remick DG, Jr., Kumar NB. Benign polyps with prostatic-type epithelium of the urethra and the urinary bladder. A suggestion of histogenesis based on histologic and immunohistochemical studies. Am J Surg Pathol 1984;8:833-839.
338. Foster RS, Garrett RA. Congenital posterior urethral polyps. J Urol 1986;136:670-672.
339. Gunther I, Abrams HJ, Sutton AP, et al. Fibroepithelial polyp of the verumontanum: a case report and review of the literature. J Urol 1979;121:525-526.
340. Schellhammer PF. Urethral carcinoma. Semin Urol 1983;1:82-89.
341. Grabstald H. Proceedings: tumors of the urethra in men and women. Cancer 1973;32:1236-1255.
342. Schellhammer PF, Whitmore WF, Jr. Transitional cell carcinoma of the urethra in men having cystectomy for bladder cancer. J Urol 1976;115:56-60.
343. Beahrs JR, Fleming TR, Zincke H. Risk of local urethral recurrence after radical cystectomy for bladder cancer. J Urol 1984;131:264-266.
344. Melicow MM, Roberts TW. Pathology and natural history of urethral tumors in males. Review of 142 cases. Urology 1978;11:83-89.
345. Bracken RB, Johnson DE, Miller LS, et al. Primary carcinoma of the female urethra. J Urol 1976;116:188-192.
346. Roberts TW, Melicow MM. Pathology and natural history of urethral tumors in females: review of 65 cases. Urology 1977;10:583-589.
347. Johnson DE, O'Connell JR. Primary carcinoma of female urethra. Urology 1983;21:42-45.
348. Clayton M, Siami P, Guinan P. Urethral diverticular carcinoma. Cancer 1992;70:665-670.
349. Thomas AA, Rackley RR, Lee U, et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol 2008;180:2463-2467.
350. Sung MT, Zhang S, MacLennan GT, et al. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res 2008;14:1947-1955.
351. Lake MH, Kossow AS, Bokinsky G. Leiomyoma of the bladder and urethra. J Urol 1981;125:742-743.
352. Murao T, Kamoi M, Asano K. Fibroma of the urinary bladder: a light and ultrastructural study of a case with review of the literature in Japan. Acta Med Okayama 1979;33:113-120.
353. Winfield HN, Catalona WJ. An isolated plexiform neurofibroma of the bladder. J Urol 1985;134:542-543.
354. Fuleihan FM, Cordonnier JJ. Hemangioma of the bladder: report of a case and review of the literature. J Urol 1969;102:581-585.
355. Proca E. Haemangioma of the bladder. Br J Urol 1977;49:60.
356. Tavora F, Montgomery E, Epstein JI. A series of vascular tumors and tumorlike lesions of the bladder. Am J Surg Pathol 2008;32:1213-1219.
357. Sukov WR, Cheville JC, Amin MB, et al. Perivascular epithelioid cell tumor (PEComa) of the urinary bladder: report of 3 cases and review of the literature. Am J Surg Pathol 2009;33:304-308.
358. Yin L, Bu H, Chen M, et al. Perivascular epithelioid cell neoplasm of the urinary bladder in an adolescent: a case report and review of the literature. Diagn Pathol 2012;7:183.
359. Williamson SR. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 2012;36:1425-1433.
360. Swartz DA, Johnson DE, Ayala AG, et al. Bladder leiomyosarcoma: a review of 10 cases with 5-year followup. J Urol 1985;133:200-202.
361. Fletcher MS, Aker M, Hill JT, et al. Granular cell myoblastoma of the bladder. Br J Urol 1985;57:109-110.
362. Mouradian JA, Coleman JW, McGovern JH, et al. Granular cell tumor (myoblastoma) of the bladder. J Urol 1974;112:343-345.
363. Mackenzie AR, Whitmore WF, Jr., Melamed MR. Myosarcomas of the bladder and prostate. Cancer 1968;22:833-844.
364. Russo P, Brady MS, Conlon K, et al. Adult urological sarcoma. J Urol. 1992;147:1032-1036; discussion 1036-1037.
365. Weitzner S. Leiomyosarcoma of urinary bladder in children. Urology 1978;12:450-452.
366. Scholtmeijer RJ, Tromp CG, Hazebroek FW. Embryonal rhabdomyosarcoma of the urogenital tract in childhood. Eur Urol 1983;9:69-74.
367. Maurer HM, Gehan EA, Beltangady M, et al. The intergroup rhabdomyosarcoma study-ii. Cancer 1993;71:1904-1922.
368. Henriksson C, Zetterlund CG, Boiesen P, et al. Large rhabdomyosarcoma of the urinary bladder in an adult. Case report. Scand J Urol Nephrol 1985;19:237-239.
369. Leuschner I, Harms D, Mattke A, et al. Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 2001;25:856-864.
370. Martin SA, Sears DL, Sebo TJ, et al. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol 2002;26:292-300.
371. Watanabe K, Baba K, Saito A, et al. Pseudosarcomatous myofibroblastic tumor and myosarcoma of the urogenital tract. Arch Pathol Lab Med 2001;125:1070-1073.
372. Henriksen OB, Mogensen P, Engelholm AJ. Inflammatory fibrous histiocytoma of the urinary bladder: clinicopathological report of a case. Acta Pathol Microbiol Immunol Scand [A] 1982;90:333-337.
373. Turner AG. Malignant fibrous histiocytoma involving the bladder. Br J Urol 1985;57:237-238.
374. Berenson RJ, Flynn S, Freiha FS, et al. Primary osteogenic sarcoma of the bladder. Case report and review of the literature. Cancer 1986;57:350-355.
375. Foote JW, Seemayer TA, Duignan JP. Desmoid tumor involving the bladder: case report. J Urol 1975;114:147-149.
376. Rosi P, Selli C, Carini M, et al. Myxoid liposarcoma of the bladder. J Urol 1983;130:560-561.
377. Mentzel T, Bainbridge TC, Katenkamp D. Solitary fibrous tumour: clinicopathological, immunohistochemical, and ultrastructural analysis of 12 cases arising in soft tissues, nasal cavity and nasopharynx, urinary bladder and prostate. Virchows Arch 1997;430:445-453.
378. Westra WH, Grenko RT, Epstein J. Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate. Hum Pathol 2000;31:63-68.
379. Corti B, Carella R, Gabusi E, et al. Solitary fibrous tumour of the urinary bladder with expression of bcl-2, cd34, and insulin-like growth factor type ii. Eur Urol 2001;39:484-488.
380. Proppe KH, Scully RE, Rosai J. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas. A report of eight cases. Am J Surg Pathol 1984;8:101-108.
381. Nochomovitz LE, Orenstein JM. Inflammatory pseudotumor of the urinary bladder-possible relationship to nodular fasciitis. Two case reports, cytologic observations, and ultrastructural observations. Am J Surg Pathol 1985;9:366-373.
382. Jones EC, Clement PB, Young RH. Inflammatory pseudotumor of the urinary bladder. A clinicopathological, immunohistochemical, ultrastructural, and flow cytometric study of 13 cases. Am J Surg Pathol 1993;17:264-274.
383. Ro JY, Ayala AG, Ordonez NG, et al. Pseudosarcomatous fibromyxoid tumor of the urinary bladder. Am J Clin Pathol 1986;86:583-590.
384. Albores-Saavedra J, Manivel JC, Essenfeld H, et al. Pseudosarcomatous myofibroblastic proliferations in the urinary bladder of children. Cancer 1990;66:1234-1241.
385. Roth JA. Reactive pseudosarcomatous response in urinary bladder. Urology 1980;16:635-637.
386. Harik LR, Merino C, Coindre JM, et al. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 2006;30:787-794.
387. Montgomery EA, Shuster DD, Burkart AL, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 2006;30:1502-1512.
388. Goldblum JR. Myofibroblastic proliferations of the genitourinary tract: reactive pseudosarcomatous proliferations or inflammatory myofibroblastic tumors? Adv Anat Pathol 2006;13:332.
389. Sukov WR, Cheville JC, Carlson AW, et al. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder. Mod Pathol 2007;20:592-603.
390. Mahadevia PS, Alexander JE, Rojas-Corona R, et al. Pseudosarcomatous stromal reaction in primary and metastatic urothelial carcinoma. A source of diagnostic difficulty. Am J Surg Pathol 1989;13:782-790.
391. Wick MR, Brown BA, Young RH, et al. Spindle-cell proliferations of the urinary tract. An immunohistochemical study. Am J Surg Pathol 1988;12:379-389.
392. Reuter VE. Sarcomatoid lesions of the urogenital tract. Semin Diagn Pathol 1993;10:188-201.
393. Young RH. Spindle cell lesions of the urinary bladder. Histol Histopathol 1990;5:505-512.
394. Iczkowski KA, Shanks JH, Gadaleanu V, et al. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms. Mod Pathol 2001;14:1043-1051.
395. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364-1371.
396. Ainsworth AM, Clark WH, Mastrangelo M, et al. Primary malignant melanoma of the urinary bladder. Cancer 1976;37:1928-1936.
397. Alroy J, Ucci AA, Heaney JA, et al. Multifocal pigmentation of prostatic and bladder urothelium. J Urol 1986;136:96-97.
398. Alroy J, Gould VE. Epithelial-stromal interface in normal and neoplastic human bladder epithelium. Ultrastruct Pathol 1980;1:201-210.
399. Chaitin BA, Manning JT, Ordonez NG. Hematologic neoplasms with initial manifestations in lower urinary tract. Urology 1984;23:35-42.
400. Makinen J, Alfthan O, Vuori J. Malignant lymphoma of the urinary bladder. A report of 2 cases. Eur Urol 1979;5:45-47.
401. Ferry A, Young R. Malignant lymphoma of the genitourinary tract. Curr Diagn Pathol 1997;4:145-169.
402. Zukerberg LR, Harris NL, Young RH. Carcinomas of the urinary bladder simulating malignant lymphoma. A report of five cases. Am J Surg Pathol 1991;15:569-576.
403. Yang CH, Krzyzaniak K, Brown WJ, et al. Primary carcinoid tumor of urinary bladder. Urology 1985;26:594-597.
404. Colby TV. Carcinoid tumor of the bladder. A case report. Arch Pathol Lab Med 1980;104:199-200.
405. Albores-Saavedra J, Maldonado ME, Ibarra J, et al. Pheochromocytoma of the urinary bladder. Cancer 1969;23:1110-1118.
406. Leestma JE, Price EB, Jr. Paraganglioma of the urinary bladder. Cancer 1971;28:1063-1073.
407. Lieberman PH. Consultation case paraganglioma in the neck of the bladder. Am J Surg Pathol 1977;1:83-84.
408. Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 1983;7:463-475.
409. Koss LG. Diagnostic Cytology. Philadelphia: JB Lippincott, 1979.
410. Voutsa NG, Melamed MR. Cytology of in situ carcinoma of the human urinary bladder. Cancer 1963;16:1307-1316.
411. Koss LG. Carcinogenesis in the human urinary bladder: observations after exposure to paraaminodiphenyl. N Engl J Med 1965;272:767-770.
412. Wolinska WH, Melamed MR, Klein FA. Cytology of bladder papilloma. Acta Cytol 1985;29:817-822.
413. Sidransky D, Messing E. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am 1992;19:629-639.
414. Cordon-Cardo C, Reuter VE. Alterations of tumor suppressor genes in bladder cancer. Semin Diagn Pathol 1997;14:123-132.
415. Dalbagni G, Presti JC J., Reuter VE, et al. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol 1993;2:4-13.
416. Fujimoto K, Yamada Y, Okajima E, et al. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res 1992;52:1393-1398.
417. Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991;252:706-709.
418. Cordon-Cardo C, Wartinger D, Petrylak D, et al. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992;84:1251-1256.
419. Cairns P, Proctor AJ, Knowles MA. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 1991;6:2305-2309.
420. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507:315-322.
421. Sjodahl G, Lovgren K, Lauss M, et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol 2013;183:681-691.
422. Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, et al. Molecular pathways of urothelial development and bladder tumorigenesis. Urol Oncol 2010;28:401-408.
423. Knowles MA. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 2006;27:361-373.
424. Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 2006;24:5552-5564.
425. Pollard C, Smith SC, Theodorescu D. Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med 2010;12:e10.
426. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005;5:713-725.
427. Billerey C, Chopin D, Aubriot-Lorton MH, et al. Frequent fgfr3 mutations in papillary non-invasive bladder (pTa) tumors. Am J Pathol 2001;158:1955-1959.
428. van Rhijn BW, Lurkin I, Radvanyi F, et al. The fibroblast growth factor receptor 3 (fgfr3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 2001;61:1265-1268.
429. Al-Ahmadie HA, Iyer G, Janakiraman M, et al. Somatic mutation of fibroblast growth factor receptor-3 (fgfr3) defines a distinct morphological subtype of high-grade urothelial carcinoma. J Pathol 2011;224:270-279.
430. Hopman AH, Kamps MA, Speel EJ, et al. Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma. Am J Pathol 2002;161:1119-1125.
431. Lindgren D, Frigyesi A, Gudjonsson S, et al. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res 2010;70:3463-3472.
432. Gui Y, Guo G, Huang Y, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 2011;43:875-878.
433. Balbas-Martinez C, Sagrera A, Carrillo-de-Santa-Pau E, et al. Recurrent inactivation of stag2 in bladder cancer is not associated with aneuploidy. Nat Genet 2013;45:1464-1469.
434. Solomon DA, Kim JS, Bondaruk J, et al. Frequent truncating mutations of stag2 in bladder cancer. Nat Genet 2013;45:1428-1430.
435. Guo G, Sun X, Chen C, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 2013;45:1459-1463.
436. Iyer G, Al-Ahmadie H, Schultz N, et al. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. J Clin Oncol 2013;31:3133-3140.
437. Iyer G, Hanrahan AJ, Milowsky MI, et al. Genome sequencing identifies a basis for everolimus sensitivity. Science 2012;338:221.
438. Juanpere N, Agell L, Lorenzo M, et al. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer. Hum Pathol 2012;43:1573-1582.
439. Kompier LC, Lurkin I, van der Aa MN, et al. FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. PLoS One 2010;5:e13821.